**Core Concept**
The patient's presentation suggests a myeloproliferative neoplasm (MPN) characterized by a clonal proliferation of hematopoietic stem cells leading to increased production of mature blood cells. The presence of abnormalities in platelet morphology and an elevated platelet count in the absence of the Philadelphia chromosome points towards a diagnosis of Essential Thrombocythemia (ET).

**Why the Correct Answer is Right**
The absence of the Philadelphia chromosome rules out Chronic Myeloid Leukemia (CML), a myeloproliferative neoplasm also characterized by an elevated platelet count. The patient's platelet count of 700 x 10^9/L, along with abnormalities in platelet morphology, is consistent with ET. ET is a myeloproliferative neoplasm characterized by the clonal proliferation of megakaryocytes, leading to an increased production of platelets. The disease is often associated with a mutation in the JAK2 gene, which is a key regulator of the JAK/STAT signaling pathway involved in platelet production.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not match the patient's presentation. The absence of the Philadelphia chromosome rules out CML.
**Option B:** This option is incorrect because the patient's platelet count and morphology do not match the typical presentation of Polycythemia Vera (PV), which is characterized by an elevated red blood cell mass.
**Option C:** This option is incorrect because the patient's presentation does not match the typical presentation of Primary Myelofibrosis (PMF), which is characterized by fibrosis of the bone marrow and a decrease in platelet count.

**Clinical Pearl / High-Yield Fact**
In the diagnosis of myeloproliferative neoplasms, the presence or absence of the Philadelphia chromosome is a critical clue. The absence of the Philadelphia chromosome helps to rule out CML and makes ET a more likely diagnosis.

**Correct Answer: D.**